Daniel Bruckner
Pediatrics · Encino, CANPI 1134432446
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,400 of the $22,566 with a category attached, or 72.7%. Biofire Diagnostics, LLC accounts for 65.2% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $14,763 and has fallen 87.0% since, to $1,926 in 2025. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $111.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofire Diagnostics, LLC$15K
- Biomerieux Inc$2K
- Supernus Pharmaceuticals, Inc.$901
- Corium, LLC$546
- Merck$482
- Regeneron Healthcare Solutions, Inc.$435
- plus $4K from 26 others
What the payments were for
- Speaking & faculty fees$16,40073%
- Food & beverage$6,16627%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofire Diagnostics, LLC | 9 | $14,719 |
| Biomerieux Inc | 4 | $1,944 |
| Supernus Pharmaceuticals, Inc. | 12 | $901 |
| Corium, LLC | 23 | $546 |
| Merck | 17 | $482 |
| Regeneron Healthcare Solutions, Inc. | 6 | $435 |
| GSK | 11 | $411 |
| Tris Pharma Inc | 10 | $336 |
| Kaleo, Inc. | 15 | $316 |
| Sanofi Pasteur Inc. | 10 | $284 |
| Sanofi-aventis U.S. LLC | 9 | $260 |
| Novo Nordisk | 5 | $250 |
| Pfizer | 10 | $216 |
| Kls-martin L.p. | 2 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $179 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $177 |
| Cranial Technologies, Inc | 10 | $168 |
| Collegium Pharmaceutical, Inc. | 8 | $164 |
| Verrica Pharmaceuticals Inc. | 7 | $149 |
| Abbott | 2 | $69 |
| Seqirus USA Inc | 3 | $69 |
| Vertical Pharmaceuticals, LLC | 3 | $46 |
| Alk-abello, Inc | 3 | $46 |
| Noven Therapeutics, LLC | 2 | $45 |
| Harmony Biosciences LLC | 1 | $31 |
| Neos Therapeutics, LP | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| AstraZeneca | 1 | $21 |
| LNHC, Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Cognoa, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Film Array$14,250
- QELBREE$585
- BioFire FilmArray$400
- DUPIXENT$231
- NEFFY$149
- VIDAS$127
- PENMENVY$125
- BEYFORTUS$110
- Wegovy$103
- ENFLONSIA$100
How this compares
$22,566 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.
Other pediatrics in Encino
- Laurene MascolaLos Angeles$451K
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Lawrence SherRolling Hills Estates$297K
- Steven BlackOakland$228K
- Jonathan StroberSan Francisco$164K
- Hasmukh AminBakersfield$140K
- Colleen KraftNewport Beach$122K
- Lela BachrachOakland$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.